REV7 counteracts DNA double-strand break resection and affects PARP inhibition
Guotai Xu(The Netherlands Cancer Institute), J. Ross Chapman(Centre for Human Genetics), Inger Brandsma(Erasmus MC), Jingsong Yuan(The University of Texas MD Anderson Cancer Center), Martin Mistrík(Institute of Molecular and Translational Medicine), Peter Bouwman(The Netherlands Cancer Institute), Jiřina Bártková(Danish Cancer Society), Ewa Gogola(The Netherlands Cancer Institute), Daniël O. Warmerdam(The Netherlands Cancer Institute), Marco Barazas(The Netherlands Cancer Institute), Janneke E. Jaspers(The Netherlands Cancer Institute), Kenji Watanabe(Danish Cancer Society), Mark Pieterse(The Netherlands Cancer Institute), Ariena Kersbergen(The Netherlands Cancer Institute), Wendy Sol(The Netherlands Cancer Institute), Patrick H. N. Celie(The Netherlands Cancer Institute), Philip C. Schouten(The Netherlands Cancer Institute), Bram van den Broek(The Netherlands Cancer Institute), Ahmed Salman(Centre for Human Genetics), Marja Nieuwland(The Netherlands Cancer Institute), Iris de Rink(The Netherlands Cancer Institute), Jorma de Ronde(The Netherlands Cancer Institute), Kees Jalink(The Netherlands Cancer Institute), Simon J. Boulton(Cancer Research UK), Junjie Chen(The University of Texas MD Anderson Cancer Center), Dik C. van Gent(Erasmus MC), Jiří Bártek(Palacký University Olomouc), Jos Jonkers(The Netherlands Cancer Institute), Piet Borst(The Netherlands Cancer Institute), Sven Rottenberg(University of Bern)
Cited by 592Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis